Orlistat wins approval as OTC weight-loss drug: the thrice-daily drug blocks up to 25% of total fat absorption in the intestine, which is then excreted.(News): An article from: Internal Medicine News
Price not available for Canada
You can still browse on Amazon. Try another country above.
Book Details
Author(s)
Alicia Ault
Publisher
Thomson Gale
ISBN / ASIN
B0010VEHA2
ISBN-13
978B0010VEHA1
Marketplace
Canada 🇨🇦
Description
This digital document is an article from Internal Medicine News, published by Thomson Gale on March 1, 2007. The length of the article is 900 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Orlistat wins approval as OTC weight-loss drug: the thrice-daily drug blocks up to 25% of total fat absorption in the intestine, which is then excreted.(News)
Author: Alicia Ault
Publication:Internal Medicine News (Magazine/Journal)
Date: March 1, 2007
Publisher: Thomson Gale
Volume: 40 Issue: 5 Page: 6(1)
Distributed by Thomson Gale
Citation Details
Title: Orlistat wins approval as OTC weight-loss drug: the thrice-daily drug blocks up to 25% of total fat absorption in the intestine, which is then excreted.(News)
Author: Alicia Ault
Publication:Internal Medicine News (Magazine/Journal)
Date: March 1, 2007
Publisher: Thomson Gale
Volume: 40 Issue: 5 Page: 6(1)
Distributed by Thomson Gale
